JOINT FILING AGREEMENT
Exhibit 99.1
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13G with respect to the securities beneficially owned by each of them of Orchard Therapeutics plc. This Joint Filing Agreement shall be included as an Exhibit to such Schedule 13G.
| Dated: November 12, 2018 | TEMASEK HOLDINGS (PRIVATE) LIMITED | |||||||
| By: | /s/ Xxxxxx Xxx Lye Whatt | |||||||
| Name | : | Xxxxxx Xxx Lye Whatt | ||||||
| Title | : | Authorized Signatory | ||||||
| Dated: November 12, 2018 | FULLERTON MANAGEMENT PTE LTD | |||||||
| By: | /s/ Cheong Xxx Xxx | |||||||
| Name | : | Cheong Xxx Xxx | ||||||
| Title | : | Director | ||||||
| Dated: November 12, 2018 | TEMASEK LIFE SCIENCES PRIVATE LIMITED | |||||||
| By: | /s/ Xxx Xxxx Xxx Xxxxxxx | |||||||
| Name | : | Xxx Xxxx Xxx Xxxxxxx | ||||||
| Title | : | Director | ||||||
